Table 2. . The conditional survival rates estimated by the integrated survival model.
Survival to year given 2-year survival | TTFields with maintenance TMZ | Maintenance TMZ alone |
---|---|---|
Year 2 | 100% | 100% |
Year 3 | 59.6% | 53.1% |
Year 4 | 45.3% | 25.7% |
Year 5 | 29.4% | 14.7% |
Year 10 | 20.7% | 10.3% |
Year 15 | 17.4% | 8.7% |
The conditional survival rates estimated by the integrated survival model at future time points given a patient has survived to 2 years.
TMZ: Maintenance temozolomide; TTFields: Tumor treating fields.